|
|
As the landscape of compounding peptides and semaglutide continues to evolve rapidly, a multitude of legal challenges and opportunities arise. This session aims to shed light on the pivotal developments and regulatory nuances in this dynamic sector.
Our speakers will delve into critical topics such as the FDA's current stance on peptide compounding, recent pronouncements from state Boards of Pharmacy, and the intricate legalities surrounding brand manufacturers. Additionally, the webi...
American College of Apothecaries
|
CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com
Terms of Service.
Site Map
